Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30

$3.87+0.15 (+4.03%)

Close on Nov 13, 2026Market cap $143.89MP/E –Yield –

Armata Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Armata Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?